Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,280 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 24,280 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 10,220 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date October 07, 2021 · Filed October 14, 2021
Section 16 reporting ended · disclosed 2021-10-14. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 22, 2026 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000076 · wk-form4_1779480532.xml · derivative · entry 3 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3 · derivative.exercise_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. F3 · derivative.expiration_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000076 · wk-form4_1779480532.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 10,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000076 · wk-form4_1779480532.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,220 Underlying: Common Stock · 10,220 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. F2 · derivative.expiration_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000109 · wk-form4_1748030638.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,387 | $20.64 | $90,547.68 |
DisclosureSEC source: 0001438133-25-000109 · wk-form4_1748030638.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000109 · wk-form4_1748030638.xml · derivative · entry 3 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,759 Underlying: Common Stock · 8,759 shares Expires not disclosed F4 · security: Awarded on May 21, 2025 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:21 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000122 · wk-form4_1716592907.xml · derivative · entry 3 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 24, 2023 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:21 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,434 | $51.73 | $229,370.82 |
DisclosureSEC source: 0001438133-24-000122 · wk-form4_1716592907.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2024 Filed May 24, 2024 23:21 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000122 · wk-form4_1716592907.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,387 Underlying: Common Stock · 4,387 shares Expires not disclosed F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:06 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000002 · wk-form4_1704747950.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:06 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,070 | $27.66 | $29,596.20 |
DisclosureSEC source: 0001438133-24-000002 · wk-form4_1704747950.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000110 · wf-form4_168513230544010.xml · derivative · entry 3 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000110 · wf-form4_168513230544010.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRSU 2023 05 24 · Derivative | 4,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000110 · wf-form4_168513230544010.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,434 Underlying: Common Stock · 4,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000002 · wf-form4_167304953982597.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070 Underlying: Common Stock · 1,069 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan F3 · derivative.exercise_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000002 · wf-form4_167304953982597.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:38 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 2,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000112 · wf-form4_165370192112956.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,757 Underlying: Common Stock · 2,757 shares Expires not disclosed F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 00:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 735 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000101 · wf-form4_165300526916138.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 735 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company. F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 00:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 735 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000101 · wf-form4_165300526916138.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:17 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000004 · wf-form4_164142826221175.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139 Underlying: Common Stock · 1,069 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company. F3 · kind: This RSU award was granted on January 4, 2021. 33% of the RSU vested on January 4, 2022 and the remaining 67% will vest annually over the next two years. F4 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:17 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000004 · wf-form4_164142826221175.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 19:28 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $288.41 | $432,615.00 |
DisclosureSEC source: 0001127602-21-024859 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,731 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 16:01 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 4,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024092 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,231 F1 · kind: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 15:27 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $269.00 | $403,500.00 |
DisclosureSEC source: 0001127602-21-022839 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,165 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 17:21 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $245.72 | $368,580.00 |
DisclosureSEC source: 0001127602-21-021160 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,665 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 17:56 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $207.13 | $310,695.00 |
DisclosureSEC source: 0001127602-21-018662 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,165 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 77.2962 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 735 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000045 · wf-form4_162156030132018.xml · derivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735 Underlying: Common Stock · 735 shares Expires not disclosed F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| May 03, 2021 Filed May 4, 2021 17:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $190.50 | $285,750.00 |
DisclosureSEC source: 0001127602-21-015115 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,588 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 15:48 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $194.14 | $291,210.00 |
DisclosureSEC source: 0001127602-21-012914 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,088 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 18:16 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $194.34 | $291,510.00 |
DisclosureSEC source: 0001127602-21-008609 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,588 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 18:28 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $203.76 | $305,640.00 |
DisclosureSEC source: 0001127602-21-003439 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,088 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 18, 2021 Filed Jan 20, 2021 01:02 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002067 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,588 F1 · shares: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on January 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:50 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 3,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000003 · wf-form4_160988343161947.xml · derivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,208 Underlying: Common Stock · 3,208 shares Expires not disclosed F1 · security: Awarded on January 4, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:45 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $213.24 | $319,860.00 |
DisclosureSEC source: 0001127602-21-000331 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,675 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $210.46 | $315,690.00 |
DisclosureSEC source: 0001127602-20-030342 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,175 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 22:50 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 10,249 | $214.74 | $2,200,870.26 |
DisclosureSEC source: 0001127602-20-029619 · form4.xml · nonDerivative · entry 2 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,675 F2 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 22:50 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 18,373 | $214.74 | $3,945,418.02 |
DisclosureSEC source: 0001127602-20-029619 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,924 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on November 17, 2020, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 11, 2020 Filed Nov 14, 2020 00:10 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,211 | $212.11 | $256,865.21 |
DisclosureSEC source: 0001127602-20-029034 · form4.xml · nonDerivative · entry 3 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,551 F4 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019. Read SEC document |
| November 11, 2020 Filed Nov 14, 2020 00:10 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,418 | $212.11 | $300,771.98 |
DisclosureSEC source: 0001127602-20-029034 · form4.xml · nonDerivative · entry 2 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,762 F3 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018. Read SEC document |
| November 11, 2020 Filed Nov 14, 2020 00:10 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 982 | $212.11 | $208,292.02 |
DisclosureSEC source: 0001127602-20-029034 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,180 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 72.85 shares of ResMed stock purchased on October 31, 2020, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 20:36 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $195.16 | $292,740.00 |
DisclosureSEC source: 0001127602-20-027979 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,089 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:46 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $172.84 | $259,260.00 |
DisclosureSEC source: 0001127602-20-026300 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,589 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:14 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $181.00 | $271,500.00 |
DisclosureSEC source: 0001127602-20-024632 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,089 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 15:13 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 7,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-023636 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,589 F1 · kind: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on August 13, 2020, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 21:13 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $200.06 | $300,090.00 |
DisclosureSEC source: 0001127602-20-022716 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,261 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 18:15 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $189.49 | $284,235.00 |
DisclosureSEC source: 0001127602-20-020804 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,761 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:22 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $160.13 | $240,195.00 |
DisclosureSEC source: 0001127602-20-018523 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,261 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 90.97 shares of ResMed stock purchased on April 30, 2020, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| May 01, 2020 Filed May 5, 2020 16:56 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $164.00 | $246,000.00 |
DisclosureSEC source: 0001127602-20-015378 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,670 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 18:46 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $140.73 | $211,095.00 |
DisclosureSEC source: 0001127602-20-012994 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,170 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 19:31 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $160.50 | $240,750.00 |
DisclosureSEC source: 0001127602-20-008853 · form4.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · President, SaaS Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,670 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.